EN1639A

Medical Condition:
EN1639A

Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

Medical Conditions Database by name

Aa Ab Ac Ad Ae Af Ag Ah Ai Aj Ak Al Am An Ao Ap Aq Ar As At Au Av Aw Ax Ay Az Ba Bb Bc Bd Be Bf Bh Bi Bj Bk Bl Bm Bn Bo Bp Br Bs Bt Bu Bv Bw By Ca Cb Cc Cd Ce Cf Cg Ci Cj Ck Cl Cm Cn Co Cp Cr Cs Ct Cu Cv Cx Cy Cz Da Db Dc Dd De Df Dg Dh Di Dj Dl Dm Dn Do Dp Dr Ds Dt Du Dw Dy Ea Eb Ec Ed Ee Ef Eg Eh Ei Ej Ek El Em En Eo Ep Eq Er Es Et Eu Ev Ew Ex Ey Ez Fa Fb Fc Fd Fe Fg Fi Fk Fl Fm Fo Fp Fr Fs Ft Fu Fx Ga Gb Gc Gd Ge Gf Gg Gh Gi Gl Gm Gn Go Gp Gr Gs Gt Gu Gv Gy Ha Hb Hc Hd He Hf Hg Hh Hi Hk Hl Hm Hn Ho Hp Hr Hs Ht Hu Hy Hz Ch Ia Ib Ic Id Ie If Ig Ih Ii Ik Il Im In Io Ip Ir Is It Iu Iv Ix Iz Ja Jb Jc Je Jh Ji Jm Jo Js Ju Ka Kb Kd Ke Kg Kh Ki Kl Kn Ko Kr Ks Ku Kv Kw Ky La Lb Lc Ld Le Lf Lh Li Ll Lm Lo Lp Lr Ls Lt Lu Ly Ma Mb Mc Md Me Mg Mh Mi Mj Mk Ml Mm Mn Mo Mp Mr Ms Mt Mu Mv My Na Nb Nc Nd Ne Nf Ng Nh Ni Nk Nl Nm No Np Nr Ns Nt Nu Ny Oa Ob Oc Od Oe Of Og Oh Oi Ok Ol Om On Oo Op Or Os Ot Ou Ov Ow Ox Oy Oz Pa Pc Pd Pe Pf Pg Ph Pi Pk Pl Pm Pn Po Pp Pr Ps Pt Pu Pv Px Py Pz Qa Qb Qh Qi Qs Qt Qu Ra Rb Rc Rd Re Rf Rg Rh Ri Rm Rn Ro Rp Rr Rs Rt Ru Rw Rx Ry Sa Sb Sc Sd Se Sf Sg Sh Si Sj Sk Sl Sm Sn So Sp Sq Sr Ss St Su Sv Sw Sy Ta Tb Tc Td Te Tf Tg Th Ti Tl Tm Tn To Tp Tq Tr Ts Tt Tu Tw Ty Ua Ub Uc Ud Ug Uj Uk Ul Um Un Up Ur Us Ut Uu Uv Uz Va Vc Vd Ve Vi Vk Vl Vm Vn Vo Vp Vs Vt Vu Vz Wa Wd We Wg Wh Wi Wk Wo Wp Wr Wt Wu Wy Xa Xe Xi Xl Xo Xp Xr Xu Xy Ya Yb Ye Yg Yh Yi Ym Yo Yp Ys Yt Yu Za Ze Zh Zi Zk Zo Zr Zu Zw Zy